| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Lung Diseases, Interstitial | 3 | 2023 | 918 | 0.660 |
Why?
|
| Renin | 9 | 2017 | 641 | 0.480 |
Why?
|
| Arthritis, Rheumatoid | 3 | 2023 | 3763 | 0.410 |
Why?
|
| Bed Rest | 7 | 2005 | 83 | 0.360 |
Why?
|
| Aldosterone | 8 | 2017 | 870 | 0.320 |
Why?
|
| Embolism | 2 | 2023 | 399 | 0.300 |
Why?
|
| Sodium, Dietary | 3 | 2017 | 425 | 0.290 |
Why?
|
| Piracetam | 3 | 2016 | 88 | 0.280 |
Why?
|
| Drug Hypersensitivity | 4 | 2017 | 917 | 0.260 |
Why?
|
| Pyridones | 2 | 2023 | 809 | 0.260 |
Why?
|
| Computer-Assisted Instruction | 3 | 2016 | 362 | 0.250 |
Why?
|
| Atrial Fibrillation | 5 | 2023 | 5127 | 0.250 |
Why?
|
| Weightlessness Simulation | 4 | 2006 | 41 | 0.250 |
Why?
|
| Thrombotic Microangiopathies | 2 | 2017 | 123 | 0.250 |
Why?
|
| Penicillins | 3 | 2017 | 402 | 0.240 |
Why?
|
| Anticonvulsants | 6 | 2016 | 1906 | 0.240 |
Why?
|
| Preoperative Care | 5 | 2018 | 2242 | 0.240 |
Why?
|
| Multiple Sclerosis, Relapsing-Remitting | 2 | 2022 | 556 | 0.230 |
Why?
|
| Reminder Systems | 2 | 2021 | 388 | 0.220 |
Why?
|
| Progesterone | 4 | 2010 | 742 | 0.220 |
Why?
|
| Renin-Angiotensin System | 5 | 2017 | 737 | 0.220 |
Why?
|
| Seizures | 5 | 2016 | 2957 | 0.210 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 4 | 2019 | 2273 | 0.210 |
Why?
|
| Anticoagulants | 7 | 2023 | 4812 | 0.210 |
Why?
|
| Diabetes Mellitus | 6 | 2018 | 5840 | 0.210 |
Why?
|
| Diet, Sodium-Restricted | 2 | 2017 | 292 | 0.210 |
Why?
|
| Middle Aged | 94 | 2022 | 220895 | 0.200 |
Why?
|
| Fertilization in Vitro | 5 | 2010 | 1292 | 0.200 |
Why?
|
| Adult | 96 | 2022 | 221177 | 0.200 |
Why?
|
| Hypotension, Orthostatic | 4 | 2006 | 258 | 0.190 |
Why?
|
| Hypoglycemia | 4 | 2019 | 883 | 0.190 |
Why?
|
| Multiple Sclerosis | 5 | 2022 | 3220 | 0.190 |
Why?
|
| Stroke | 5 | 2023 | 9757 | 0.190 |
Why?
|
| Female | 117 | 2023 | 392644 | 0.190 |
Why?
|
| Cephalosporins | 3 | 2017 | 198 | 0.190 |
Why?
|
| Sodium Chloride, Dietary | 3 | 2010 | 293 | 0.190 |
Why?
|
| Abortion, Induced | 2 | 2019 | 462 | 0.180 |
Why?
|
| Male | 104 | 2021 | 360804 | 0.180 |
Why?
|
| Counseling | 3 | 2019 | 1547 | 0.170 |
Why?
|
| Humans | 152 | 2023 | 761504 | 0.170 |
Why?
|
| Latent Tuberculosis | 1 | 2022 | 224 | 0.170 |
Why?
|
| Abortion, Eugenic | 1 | 2019 | 39 | 0.170 |
Why?
|
| Vacuum Curettage | 1 | 2019 | 45 | 0.160 |
Why?
|
| Tuberculosis | 2 | 2022 | 2017 | 0.160 |
Why?
|
| Gels | 2 | 2019 | 420 | 0.160 |
Why?
|
| Laxatives | 1 | 2019 | 92 | 0.160 |
Why?
|
| Inpatients | 5 | 2019 | 2548 | 0.160 |
Why?
|
| Substantia Nigra | 1 | 2020 | 350 | 0.160 |
Why?
|
| Embryo Transfer | 3 | 2010 | 522 | 0.160 |
Why?
|
| Angiotensin II | 6 | 2010 | 849 | 0.150 |
Why?
|
| Phenytoin | 2 | 2009 | 190 | 0.150 |
Why?
|
| Colonoscopy | 3 | 2021 | 1394 | 0.150 |
Why?
|
| Cyclooxygenase Inhibitors | 2 | 2013 | 361 | 0.150 |
Why?
|
| Hospitals, General | 2 | 2021 | 798 | 0.150 |
Why?
|
| Intramolecular Oxidoreductases | 1 | 2018 | 105 | 0.150 |
Why?
|
| Melatonin | 1 | 2003 | 669 | 0.150 |
Why?
|
| Respiratory Therapy | 1 | 2018 | 125 | 0.150 |
Why?
|
| Labor, Induced | 1 | 2019 | 151 | 0.150 |
Why?
|
| Hydrocortisone | 4 | 2004 | 1819 | 0.150 |
Why?
|
| Neuroprotective Agents | 2 | 2016 | 957 | 0.150 |
Why?
|
| Aged | 61 | 2021 | 169289 | 0.150 |
Why?
|
| Lipocalins | 1 | 2018 | 161 | 0.140 |
Why?
|
| beta 2-Microglobulin | 1 | 2018 | 329 | 0.140 |
Why?
|
| Observation | 1 | 2019 | 310 | 0.140 |
Why?
|
| Cystatin C | 1 | 2018 | 269 | 0.140 |
Why?
|
| Coronary Sinus | 1 | 2017 | 84 | 0.140 |
Why?
|
| Sweetening Agents | 1 | 2019 | 290 | 0.140 |
Why?
|
| Bradykinin | 1 | 2016 | 208 | 0.130 |
Why?
|
| Leukemia | 6 | 1987 | 1522 | 0.130 |
Why?
|
| Choroid Plexus Neoplasms | 1 | 2016 | 38 | 0.130 |
Why?
|
| Licensure | 1 | 2017 | 128 | 0.130 |
Why?
|
| Eye Pain | 1 | 2016 | 46 | 0.130 |
Why?
|
| Densitometry | 1 | 2016 | 151 | 0.130 |
Why?
|
| Adaptation, Physiological | 4 | 2006 | 1301 | 0.130 |
Why?
|
| Angioedemas, Hereditary | 1 | 2016 | 91 | 0.130 |
Why?
|
| Administration, Inhalation | 1 | 2018 | 1157 | 0.130 |
Why?
|
| Cacao | 2 | 2013 | 98 | 0.130 |
Why?
|
| Nursing Staff, Hospital | 1 | 2019 | 348 | 0.130 |
Why?
|
| Plasma Exchange | 1 | 2016 | 158 | 0.120 |
Why?
|
| Carbon Monoxide | 1 | 2018 | 547 | 0.120 |
Why?
|
| Hyperglycemia | 2 | 2014 | 1376 | 0.120 |
Why?
|
| Drug Prescriptions | 2 | 2015 | 1670 | 0.120 |
Why?
|
| Caloric Restriction | 1 | 2017 | 299 | 0.120 |
Why?
|
| Nurse Practitioners | 2 | 2016 | 271 | 0.120 |
Why?
|
| Cardiovascular Deconditioning | 2 | 2005 | 9 | 0.120 |
Why?
|
| Eicosanoids | 1 | 2017 | 282 | 0.120 |
Why?
|
| Blood Pressure | 8 | 2017 | 8481 | 0.120 |
Why?
|
| Tuberculosis, Pulmonary | 1 | 2021 | 832 | 0.120 |
Why?
|
| Retrospective Studies | 33 | 2021 | 80636 | 0.120 |
Why?
|
| Puerperal Disorders | 1 | 2017 | 299 | 0.120 |
Why?
|
| Acetamides | 1 | 2016 | 256 | 0.120 |
Why?
|
| Albuminuria | 1 | 2018 | 657 | 0.120 |
Why?
|
| Coronary Vessel Anomalies | 1 | 2017 | 307 | 0.110 |
Why?
|
| Thromboembolism | 1 | 2020 | 995 | 0.110 |
Why?
|
| Weightlessness | 2 | 2005 | 102 | 0.110 |
Why?
|
| Epilepsy | 4 | 2012 | 3290 | 0.110 |
Why?
|
| Pain Measurement | 2 | 2016 | 3550 | 0.110 |
Why?
|
| Laryngeal Nerves | 1 | 2014 | 57 | 0.110 |
Why?
|
| Sepsis | 3 | 2018 | 2585 | 0.110 |
Why?
|
| Endocrine System | 2 | 2005 | 114 | 0.110 |
Why?
|
| Infant, Newborn, Diseases | 1 | 2019 | 589 | 0.110 |
Why?
|
| Hypertension | 7 | 2005 | 8540 | 0.110 |
Why?
|
| Vasoconstrictor Agents | 3 | 2017 | 654 | 0.110 |
Why?
|
| Patient Satisfaction | 4 | 2012 | 3461 | 0.110 |
Why?
|
| Glucose | 2 | 2019 | 4346 | 0.110 |
Why?
|
| Adrenal Glands | 3 | 2001 | 552 | 0.110 |
Why?
|
| Tuberculosis, Multidrug-Resistant | 1 | 2021 | 934 | 0.110 |
Why?
|
| Head-Down Tilt | 7 | 2006 | 65 | 0.110 |
Why?
|
| Intracranial Hemorrhages | 1 | 2019 | 822 | 0.110 |
Why?
|
| Fatigue | 1 | 2020 | 1552 | 0.110 |
Why?
|
| Ketorolac | 1 | 2013 | 94 | 0.110 |
Why?
|
| Blood Glucose | 5 | 2019 | 6391 | 0.110 |
Why?
|
| Brain Waves | 1 | 2017 | 408 | 0.110 |
Why?
|
| Insulin | 3 | 2018 | 6596 | 0.110 |
Why?
|
| Anti-Bacterial Agents | 4 | 2017 | 7407 | 0.110 |
Why?
|
| Luteal Phase | 2 | 2010 | 138 | 0.100 |
Why?
|
| Ependymoma | 1 | 2016 | 320 | 0.100 |
Why?
|
| Air Ambulances | 1 | 2014 | 92 | 0.100 |
Why?
|
| Patient Care Planning | 1 | 2018 | 908 | 0.100 |
Why?
|
| Blood Coagulation | 1 | 2019 | 1154 | 0.100 |
Why?
|
| Osteoarthritis, Hip | 2 | 2010 | 409 | 0.100 |
Why?
|
| Professional Competence | 1 | 2016 | 431 | 0.100 |
Why?
|
| Fibromyalgia | 3 | 2003 | 405 | 0.100 |
Why?
|
| Laryngoscopy | 2 | 2015 | 706 | 0.100 |
Why?
|
| Cystoscopy | 1 | 2012 | 131 | 0.100 |
Why?
|
| Osteoporosis, Postmenopausal | 4 | 2003 | 396 | 0.100 |
Why?
|
| Allergy and Immunology | 1 | 2014 | 176 | 0.100 |
Why?
|
| Surgical Procedures, Operative | 2 | 2014 | 1922 | 0.100 |
Why?
|
| Bone Density | 6 | 2010 | 3551 | 0.100 |
Why?
|
| Atovaquone | 1 | 2012 | 56 | 0.100 |
Why?
|
| Lipoxins | 2 | 2005 | 419 | 0.100 |
Why?
|
| Aged, 80 and over | 23 | 2019 | 58976 | 0.100 |
Why?
|
| Aspergillosis | 4 | 1987 | 242 | 0.100 |
Why?
|
| Ibuprofen | 1 | 2013 | 229 | 0.100 |
Why?
|
| Circadian Rhythm | 1 | 2003 | 2576 | 0.100 |
Why?
|
| Practice Guidelines as Topic | 4 | 2019 | 7390 | 0.100 |
Why?
|
| Hypothermia, Induced | 1 | 2017 | 753 | 0.100 |
Why?
|
| Docosahexaenoic Acids | 2 | 2017 | 908 | 0.100 |
Why?
|
| Lichen Planus, Oral | 1 | 2012 | 57 | 0.100 |
Why?
|
| Automobile Driving | 1 | 2017 | 441 | 0.100 |
Why?
|
| Shock, Septic | 1 | 2018 | 768 | 0.100 |
Why?
|
| Supratentorial Neoplasms | 2 | 2010 | 159 | 0.100 |
Why?
|
| Respiratory Insufficiency | 2 | 2018 | 1230 | 0.100 |
Why?
|
| Pneumocystis carinii | 1 | 2012 | 72 | 0.100 |
Why?
|
| Microglia | 1 | 2020 | 1361 | 0.100 |
Why?
|
| Platelet Factor 4 | 1 | 2011 | 129 | 0.090 |
Why?
|
| Length of Stay | 5 | 2018 | 6425 | 0.090 |
Why?
|
| Accidents, Traffic | 1 | 2017 | 816 | 0.090 |
Why?
|
| Lupus Nephritis | 2 | 2005 | 316 | 0.090 |
Why?
|
| Education | 1 | 2014 | 537 | 0.090 |
Why?
|
| Primary Ovarian Insufficiency | 1 | 2011 | 107 | 0.090 |
Why?
|
| Carboplatin | 1 | 2014 | 794 | 0.090 |
Why?
|
| Young Adult | 21 | 2019 | 59243 | 0.090 |
Why?
|
| Agranulocytosis | 4 | 1987 | 97 | 0.090 |
Why?
|
| Positron-Emission Tomography | 3 | 2020 | 6485 | 0.090 |
Why?
|
| Injections, Intramuscular | 5 | 2013 | 554 | 0.090 |
Why?
|
| Intensive Care Units | 3 | 2020 | 3745 | 0.090 |
Why?
|
| Drug Utilization | 1 | 2017 | 1188 | 0.090 |
Why?
|
| Spironolactone | 1 | 2014 | 412 | 0.090 |
Why?
|
| Plagiarism | 1 | 2010 | 22 | 0.090 |
Why?
|
| Statistics as Topic | 3 | 2007 | 2358 | 0.090 |
Why?
|
| Radiopharmaceuticals | 2 | 2018 | 2651 | 0.090 |
Why?
|
| Pneumonia, Pneumocystis | 1 | 2012 | 242 | 0.090 |
Why?
|
| Airway Management | 1 | 2014 | 312 | 0.090 |
Why?
|
| Vocal Cord Paralysis | 1 | 2014 | 272 | 0.090 |
Why?
|
| Mycobacterium tuberculosis | 1 | 2021 | 1914 | 0.090 |
Why?
|
| Warfarin | 1 | 2019 | 1483 | 0.090 |
Why?
|
| Treatment Outcome | 21 | 2022 | 64680 | 0.090 |
Why?
|
| Double-Blind Method | 9 | 2022 | 12341 | 0.090 |
Why?
|
| Intubation, Intratracheal | 2 | 2015 | 1329 | 0.090 |
Why?
|
| Vitamin D Deficiency | 3 | 2008 | 1388 | 0.090 |
Why?
|
| Brain | 7 | 2022 | 27112 | 0.090 |
Why?
|
| Home Care Services | 1 | 2016 | 648 | 0.090 |
Why?
|
| Patient Participation | 1 | 2019 | 1444 | 0.090 |
Why?
|
| Sound | 1 | 2012 | 257 | 0.090 |
Why?
|
| Atrophy | 3 | 2022 | 1633 | 0.080 |
Why?
|
| Glomerular Filtration Rate | 1 | 2018 | 2176 | 0.080 |
Why?
|
| Contraceptives, Oral, Combined | 1 | 2010 | 116 | 0.080 |
Why?
|
| Premedication | 2 | 2009 | 246 | 0.080 |
Why?
|
| Microcirculation | 1 | 2014 | 1273 | 0.080 |
Why?
|
| Hospital Mortality | 3 | 2018 | 5294 | 0.080 |
Why?
|
| Boston | 7 | 2018 | 9326 | 0.080 |
Why?
|
| Diabetic Angiopathies | 1 | 2014 | 803 | 0.080 |
Why?
|
| Patient Compliance | 1 | 2019 | 2690 | 0.080 |
Why?
|
| Skin Tests | 3 | 2017 | 637 | 0.080 |
Why?
|
| Flavonoids | 1 | 2012 | 445 | 0.080 |
Why?
|
| Contraceptives, Oral, Hormonal | 1 | 2010 | 190 | 0.080 |
Why?
|
| AIDS-Related Opportunistic Infections | 3 | 1998 | 662 | 0.080 |
Why?
|
| Health Behavior | 1 | 2021 | 2643 | 0.080 |
Why?
|
| Analgesia | 1 | 2013 | 461 | 0.080 |
Why?
|
| Insulin Resistance | 3 | 2017 | 3963 | 0.080 |
Why?
|
| Pre-Eclampsia | 2 | 2017 | 1231 | 0.080 |
Why?
|
| Desensitization, Immunologic | 1 | 2014 | 556 | 0.080 |
Why?
|
| Uterine Hemorrhage | 1 | 2010 | 240 | 0.080 |
Why?
|
| Forkhead Transcription Factors | 1 | 2016 | 1616 | 0.080 |
Why?
|
| Radioimmunoassay | 2 | 2000 | 862 | 0.080 |
Why?
|
| Coronary Circulation | 1 | 2014 | 1569 | 0.080 |
Why?
|
| Thromboxane B2 | 2 | 2005 | 143 | 0.080 |
Why?
|
| Acetanilides | 2 | 2020 | 169 | 0.080 |
Why?
|
| Oncogene Proteins, Fusion | 1 | 2016 | 1606 | 0.080 |
Why?
|
| Hospitals, Teaching | 2 | 2010 | 1156 | 0.080 |
Why?
|
| Spinal Cord | 1 | 2016 | 1818 | 0.080 |
Why?
|
| Thyroidectomy | 1 | 2014 | 907 | 0.080 |
Why?
|
| Femur Neck | 1 | 2010 | 314 | 0.080 |
Why?
|
| Creatinine | 6 | 2018 | 1899 | 0.080 |
Why?
|
| Medical Staff, Hospital | 1 | 2012 | 601 | 0.070 |
Why?
|
| Beverages | 1 | 2013 | 821 | 0.070 |
Why?
|
| Emergency Service, Hospital | 2 | 2019 | 7879 | 0.070 |
Why?
|
| Adolescent | 24 | 2019 | 88319 | 0.070 |
Why?
|
| Videotape Recording | 1 | 2009 | 337 | 0.070 |
Why?
|
| Nerve Fibers, Myelinated | 1 | 2013 | 952 | 0.070 |
Why?
|
| Hysterectomy | 1 | 2012 | 857 | 0.070 |
Why?
|
| Risk Factors | 15 | 2023 | 74206 | 0.070 |
Why?
|
| Psychophysiologic Disorders | 1 | 2009 | 221 | 0.070 |
Why?
|
| Acoustic Stimulation | 1 | 2012 | 1235 | 0.070 |
Why?
|
| Monitoring, Intraoperative | 1 | 2014 | 942 | 0.070 |
Why?
|
| Absorptiometry, Photon | 3 | 2010 | 1738 | 0.070 |
Why?
|
| Time Factors | 14 | 2019 | 39967 | 0.070 |
Why?
|
| Heart Arrest | 1 | 2017 | 1514 | 0.070 |
Why?
|
| Subcutaneous Fat | 1 | 2010 | 393 | 0.070 |
Why?
|
| Consultants | 1 | 2007 | 56 | 0.070 |
Why?
|
| Parenteral Nutrition, Total | 1 | 1988 | 304 | 0.070 |
Why?
|
| Antigens, Fungal | 1 | 1987 | 69 | 0.070 |
Why?
|
| Immobilization | 2 | 2006 | 229 | 0.070 |
Why?
|
| Potassium | 6 | 2010 | 1311 | 0.070 |
Why?
|
| Blood Gas Analysis | 2 | 2018 | 379 | 0.070 |
Why?
|
| Paclitaxel | 1 | 2014 | 1732 | 0.070 |
Why?
|
| Kidney | 6 | 2017 | 7048 | 0.070 |
Why?
|
| Allergens | 1 | 2014 | 1432 | 0.070 |
Why?
|
| Nitrogen | 1 | 1988 | 348 | 0.070 |
Why?
|
| Magnetic Resonance Imaging, Interventional | 1 | 2008 | 187 | 0.070 |
Why?
|
| Catheter Ablation | 2 | 2011 | 2751 | 0.070 |
Why?
|
| Accidental Falls | 2 | 2019 | 1068 | 0.070 |
Why?
|
| Follow-Up Studies | 14 | 2018 | 39106 | 0.070 |
Why?
|
| Prospective Studies | 13 | 2021 | 54425 | 0.070 |
Why?
|
| Leg | 3 | 2005 | 1088 | 0.060 |
Why?
|
| Sodium | 6 | 2010 | 1588 | 0.060 |
Why?
|
| Hip Fractures | 2 | 2008 | 988 | 0.060 |
Why?
|
| Aspergillus fumigatus | 1 | 1987 | 157 | 0.060 |
Why?
|
| Pleural Neoplasms | 1 | 2010 | 609 | 0.060 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2017 | 2790 | 0.060 |
Why?
|
| Aerospace Medicine | 1 | 2006 | 95 | 0.060 |
Why?
|
| Referral and Consultation | 1 | 2018 | 3600 | 0.060 |
Why?
|
| Respiration | 1 | 2012 | 1657 | 0.060 |
Why?
|
| Maps as Topic | 1 | 1984 | 18 | 0.060 |
Why?
|
| Hemodynamics | 3 | 2005 | 4159 | 0.060 |
Why?
|
| Vaginal Creams, Foams, and Jellies | 3 | 2010 | 62 | 0.060 |
Why?
|
| Massachusetts | 4 | 2020 | 8830 | 0.060 |
Why?
|
| Intra-Abdominal Fat | 1 | 2010 | 613 | 0.060 |
Why?
|
| Benzhydryl Compounds | 1 | 2012 | 916 | 0.060 |
Why?
|
| Efficiency, Organizational | 1 | 2010 | 695 | 0.060 |
Why?
|
| Mammography | 1 | 2016 | 2430 | 0.060 |
Why?
|
| Needles | 1 | 2008 | 451 | 0.060 |
Why?
|
| Carcinoma | 1 | 2016 | 2330 | 0.060 |
Why?
|
| Estradiol | 2 | 2010 | 1937 | 0.060 |
Why?
|
| Attitude of Health Personnel | 1 | 2019 | 3889 | 0.060 |
Why?
|
| Anti-Infective Agents | 1 | 2012 | 983 | 0.060 |
Why?
|
| Fatty Acids, Unsaturated | 1 | 2008 | 540 | 0.060 |
Why?
|
| Hypoglycemic Agents | 2 | 2018 | 3085 | 0.060 |
Why?
|
| Registries | 1 | 2020 | 8224 | 0.060 |
Why?
|
| Medical Order Entry Systems | 1 | 2009 | 521 | 0.060 |
Why?
|
| Heparin | 1 | 2011 | 1634 | 0.060 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2018 | 2243 | 0.060 |
Why?
|
| Mesothelioma | 1 | 2010 | 807 | 0.060 |
Why?
|
| Sensitivity and Specificity | 5 | 2017 | 14666 | 0.060 |
Why?
|
| Magnetic Resonance Imaging | 5 | 2022 | 36426 | 0.060 |
Why?
|
| Systole | 2 | 2003 | 936 | 0.060 |
Why?
|
| Insulin-Like Growth Factor I | 2 | 2003 | 1934 | 0.060 |
Why?
|
| Insurance, Health | 1 | 2016 | 2498 | 0.060 |
Why?
|
| Reproducibility of Results | 6 | 2017 | 20098 | 0.060 |
Why?
|
| Angiotensinogen | 2 | 2001 | 161 | 0.060 |
Why?
|
| Risk Assessment | 4 | 2019 | 23995 | 0.060 |
Why?
|
| Liver Neoplasms | 2 | 2011 | 4320 | 0.060 |
Why?
|
| Thrombocytopenia | 1 | 2011 | 1181 | 0.060 |
Why?
|
| Brain Ischemia | 1 | 2017 | 3049 | 0.060 |
Why?
|
| Biometry | 1 | 2007 | 563 | 0.060 |
Why?
|
| Body Composition | 2 | 2011 | 2426 | 0.060 |
Why?
|
| Plethysmography | 3 | 2012 | 175 | 0.050 |
Why?
|
| Clomiphene | 1 | 2003 | 71 | 0.050 |
Why?
|
| Age Factors | 10 | 2010 | 18395 | 0.050 |
Why?
|
| Natriuresis | 1 | 2003 | 105 | 0.050 |
Why?
|
| Aspirin | 2 | 2005 | 3133 | 0.050 |
Why?
|
| Pilot Projects | 5 | 2022 | 8631 | 0.050 |
Why?
|
| Postoperative Complications | 3 | 2018 | 15631 | 0.050 |
Why?
|
| Sex Factors | 7 | 2010 | 10552 | 0.050 |
Why?
|
| Glia Maturation Factor | 1 | 2022 | 13 | 0.050 |
Why?
|
| Cerebrovascular Circulation | 1 | 2013 | 2727 | 0.050 |
Why?
|
| Etidronic Acid | 1 | 2003 | 63 | 0.050 |
Why?
|
| Meningioma | 1 | 2012 | 1218 | 0.050 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 3084 | 0.050 |
Why?
|
| Kidney Failure, Chronic | 3 | 2012 | 2471 | 0.050 |
Why?
|
| Selective Estrogen Receptor Modulators | 1 | 2003 | 132 | 0.050 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 3204 | 0.050 |
Why?
|
| Renal Circulation | 1 | 2003 | 291 | 0.050 |
Why?
|
| Syncope | 1 | 2005 | 427 | 0.050 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 2 | 2014 | 1516 | 0.050 |
Why?
|
| Skin Neoplasms | 2 | 2021 | 5821 | 0.050 |
Why?
|
| Brain Neoplasms | 2 | 2016 | 9031 | 0.050 |
Why?
|
| Meningeal Neoplasms | 1 | 2012 | 1248 | 0.050 |
Why?
|
| Internship and Residency | 3 | 2012 | 5880 | 0.050 |
Why?
|
| Critical Care | 1 | 2015 | 2696 | 0.050 |
Why?
|
| Bilirubin | 2 | 2017 | 436 | 0.050 |
Why?
|
| Temporal Lobe | 1 | 2010 | 1695 | 0.050 |
Why?
|
| Predictive Value of Tests | 6 | 2018 | 15266 | 0.050 |
Why?
|
| Head and Neck Neoplasms | 1 | 2016 | 2895 | 0.050 |
Why?
|
| Radiology | 1 | 2016 | 2113 | 0.050 |
Why?
|
| Pregnancy Rate | 3 | 2010 | 648 | 0.050 |
Why?
|
| Tuberculin Test | 1 | 2022 | 206 | 0.050 |
Why?
|
| Teaching | 1 | 2009 | 1170 | 0.050 |
Why?
|
| France | 1 | 2003 | 497 | 0.050 |
Why?
|
| Thyrotropin | 1 | 2005 | 834 | 0.050 |
Why?
|
| Myocardial Infarction | 2 | 2020 | 11460 | 0.050 |
Why?
|
| Nuclear Proteins | 1 | 2016 | 5796 | 0.050 |
Why?
|
| Appointments and Schedules | 2 | 2019 | 443 | 0.050 |
Why?
|
| Neutropenia | 1 | 1987 | 885 | 0.050 |
Why?
|
| Purpura, Thrombotic Thrombocytopenic | 2 | 2017 | 130 | 0.050 |
Why?
|
| Immunoradiometric Assay | 1 | 2001 | 20 | 0.050 |
Why?
|
| Space Perception | 1 | 1984 | 465 | 0.050 |
Why?
|
| Weight Gain | 1 | 2011 | 2348 | 0.050 |
Why?
|
| Body Mass Index | 6 | 2017 | 12953 | 0.050 |
Why?
|
| Mothers | 1 | 2012 | 2198 | 0.050 |
Why?
|
| Fibrinolytic Agents | 2 | 2021 | 2084 | 0.050 |
Why?
|
| Italy | 1 | 2003 | 842 | 0.050 |
Why?
|
| Follicle Stimulating Hormone | 1 | 2003 | 726 | 0.050 |
Why?
|
| Enzyme Precursors | 1 | 2001 | 170 | 0.050 |
Why?
|
| Diastole | 1 | 2003 | 782 | 0.040 |
Why?
|
| Protective Clothing | 1 | 2021 | 103 | 0.040 |
Why?
|
| Healthcare Disparities | 1 | 2016 | 3358 | 0.040 |
Why?
|
| Chi-Square Distribution | 3 | 2012 | 3416 | 0.040 |
Why?
|
| Penicillin G | 1 | 2000 | 40 | 0.040 |
Why?
|
| Supine Position | 1 | 2001 | 205 | 0.040 |
Why?
|
| Emergency Medicine | 1 | 2009 | 1198 | 0.040 |
Why?
|
| Cohort Studies | 8 | 2019 | 41487 | 0.040 |
Why?
|
| Neuropsychological Tests | 1 | 2013 | 7045 | 0.040 |
Why?
|
| Antiviral Agents | 3 | 1998 | 3060 | 0.040 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 5 | 2011 | 11742 | 0.040 |
Why?
|
| Decision Support Systems, Clinical | 1 | 2009 | 1175 | 0.040 |
Why?
|
| Sex | 1 | 2000 | 53 | 0.040 |
Why?
|
| Heroin Dependence | 1 | 1981 | 172 | 0.040 |
Why?
|
| Prognosis | 8 | 2018 | 29625 | 0.040 |
Why?
|
| Endothelium, Vascular | 1 | 2012 | 4431 | 0.040 |
Why?
|
| Neurosyphilis | 1 | 2000 | 27 | 0.040 |
Why?
|
| Sunscreening Agents | 1 | 2021 | 139 | 0.040 |
Why?
|
| Feeding Behavior | 1 | 2012 | 3188 | 0.040 |
Why?
|
| Pregnancy | 9 | 2019 | 29874 | 0.040 |
Why?
|
| Lung Diseases, Fungal | 3 | 1985 | 126 | 0.040 |
Why?
|
| Energy Intake | 1 | 1988 | 2134 | 0.040 |
Why?
|
| Lower Extremity | 1 | 2008 | 1202 | 0.040 |
Why?
|
| Acyclovir | 2 | 1998 | 268 | 0.040 |
Why?
|
| Kidney Transplantation | 2 | 2012 | 4234 | 0.040 |
Why?
|
| Severity of Illness Index | 7 | 2018 | 15842 | 0.040 |
Why?
|
| Delivery of Health Care | 1 | 2017 | 5336 | 0.040 |
Why?
|
| Dehydroepiandrosterone Sulfate | 1 | 2000 | 241 | 0.040 |
Why?
|
| Sex Characteristics | 2 | 2010 | 2639 | 0.040 |
Why?
|
| Disease Susceptibility | 2 | 2022 | 1787 | 0.040 |
Why?
|
| Ceftriaxone | 1 | 2000 | 175 | 0.040 |
Why?
|
| Carboxyhemoglobin | 1 | 2018 | 83 | 0.040 |
Why?
|
| Heart | 1 | 2012 | 4404 | 0.040 |
Why?
|
| Collagen | 2 | 2005 | 2638 | 0.040 |
Why?
|
| Medication Adherence | 1 | 2010 | 2176 | 0.040 |
Why?
|
| Quality of Health Care | 2 | 2012 | 4330 | 0.040 |
Why?
|
| Public Opinion | 1 | 1982 | 484 | 0.040 |
Why?
|
| Peru | 1 | 2021 | 891 | 0.040 |
Why?
|
| Ultrasonography | 2 | 2009 | 5972 | 0.040 |
Why?
|
| Mental Disorders | 1 | 2018 | 6845 | 0.040 |
Why?
|
| General Surgery | 1 | 2009 | 1692 | 0.040 |
Why?
|
| Carbon Dioxide | 1 | 2022 | 1147 | 0.040 |
Why?
|
| Human Growth Hormone | 1 | 2003 | 642 | 0.040 |
Why?
|
| Bone Marrow Transplantation | 1 | 1986 | 2693 | 0.040 |
Why?
|
| Infusions, Intravenous | 3 | 2018 | 2219 | 0.040 |
Why?
|
| Animal Nutritional Physiological Phenomena | 1 | 2017 | 56 | 0.040 |
Why?
|
| Infant Formula | 1 | 2019 | 194 | 0.040 |
Why?
|
| Breast Neoplasms | 3 | 2016 | 21012 | 0.040 |
Why?
|
| Cysts | 1 | 2003 | 681 | 0.040 |
Why?
|
| Thrombosis | 1 | 2011 | 2942 | 0.040 |
Why?
|
| Foscarnet | 1 | 1997 | 35 | 0.040 |
Why?
|
| Nicotinamide Phosphoribosyltransferase | 1 | 2017 | 83 | 0.040 |
Why?
|
| Premenopause | 3 | 2011 | 1039 | 0.040 |
Why?
|
| Sleep Deprivation | 1 | 2004 | 846 | 0.040 |
Why?
|
| Zona Glomerulosa | 1 | 2017 | 87 | 0.040 |
Why?
|
| Hyperparathyroidism | 1 | 1999 | 337 | 0.040 |
Why?
|
| Neurosurgical Procedures | 1 | 2008 | 2072 | 0.040 |
Why?
|
| Electroencephalography | 2 | 2012 | 6225 | 0.040 |
Why?
|
| Education, Medical, Graduate | 1 | 2009 | 2373 | 0.040 |
Why?
|
| Fetal Death | 1 | 2019 | 435 | 0.040 |
Why?
|
| International Normalized Ratio | 1 | 2019 | 382 | 0.030 |
Why?
|
| South Africa | 1 | 2022 | 1842 | 0.030 |
Why?
|
| Cytomegalovirus Retinitis | 1 | 1997 | 56 | 0.030 |
Why?
|
| Incidence | 4 | 2022 | 21353 | 0.030 |
Why?
|
| Organothiophosphorus Compounds | 2 | 1986 | 14 | 0.030 |
Why?
|
| Observer Variation | 1 | 2003 | 2606 | 0.030 |
Why?
|
| Amifostine | 2 | 1986 | 40 | 0.030 |
Why?
|
| Parathyroidectomy | 1 | 1999 | 242 | 0.030 |
Why?
|
| Diuretics | 2 | 2014 | 610 | 0.030 |
Why?
|
| Discriminant Analysis | 1 | 2017 | 222 | 0.030 |
Why?
|
| Hyperaldosteronism | 1 | 2000 | 247 | 0.030 |
Why?
|
| Blood Chemical Analysis | 1 | 2018 | 437 | 0.030 |
Why?
|
| Venous Thromboembolism | 1 | 2009 | 1866 | 0.030 |
Why?
|
| Ganciclovir | 1 | 1997 | 252 | 0.030 |
Why?
|
| Putamen | 1 | 2017 | 292 | 0.030 |
Why?
|
| Trifluridine | 1 | 1996 | 28 | 0.030 |
Why?
|
| Glomerulosclerosis, Focal Segmental | 1 | 1999 | 335 | 0.030 |
Why?
|
| Clinical Competence | 1 | 2012 | 4792 | 0.030 |
Why?
|
| Pregnancy Trimester, Second | 1 | 2019 | 731 | 0.030 |
Why?
|
| Parathyroid Hormone | 2 | 2000 | 1803 | 0.030 |
Why?
|
| Globus Pallidus | 1 | 2017 | 250 | 0.030 |
Why?
|
| Ependyma | 1 | 2016 | 56 | 0.030 |
Why?
|
| Partial Thromboplastin Time | 1 | 2017 | 204 | 0.030 |
Why?
|
| Valine | 1 | 1998 | 408 | 0.030 |
Why?
|
| Urinalysis | 1 | 2018 | 368 | 0.030 |
Why?
|
| Case-Control Studies | 6 | 2017 | 22176 | 0.030 |
Why?
|
| Bicarbonates | 1 | 2017 | 292 | 0.030 |
Why?
|
| Thyroid Nodule | 1 | 2003 | 764 | 0.030 |
Why?
|
| Arthroplasty, Replacement, Hip | 2 | 2003 | 1413 | 0.030 |
Why?
|
| Aging | 4 | 2010 | 8708 | 0.030 |
Why?
|
| Immunocompromised Host | 1 | 2021 | 856 | 0.030 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2005 | 2244 | 0.030 |
Why?
|
| Self Administration | 1 | 2016 | 390 | 0.030 |
Why?
|
| Kidney Diseases | 1 | 2006 | 2091 | 0.030 |
Why?
|
| Hormones | 1 | 1999 | 869 | 0.030 |
Why?
|
| Injections, Subcutaneous | 1 | 2016 | 681 | 0.030 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2021 | 1937 | 0.030 |
Why?
|
| Education, Medical | 1 | 2007 | 1725 | 0.030 |
Why?
|
| Automation | 1 | 2017 | 586 | 0.030 |
Why?
|
| Hypothalamo-Hypophyseal System | 1 | 1999 | 701 | 0.030 |
Why?
|
| Adaptation, Psychological | 1 | 1986 | 2629 | 0.030 |
Why?
|
| Glioma | 1 | 2010 | 3455 | 0.030 |
Why?
|
| Cyclophosphamide | 3 | 2011 | 2218 | 0.030 |
Why?
|
| Glasgow Coma Scale | 1 | 2017 | 580 | 0.030 |
Why?
|
| Hydrochlorothiazide | 1 | 2014 | 94 | 0.030 |
Why?
|
| Reference Values | 3 | 2010 | 4920 | 0.030 |
Why?
|
| Drug Tolerance | 2 | 2008 | 367 | 0.030 |
Why?
|
| Oncology Service, Hospital | 1 | 2014 | 57 | 0.030 |
Why?
|
| Congenital Abnormalities | 1 | 2019 | 709 | 0.030 |
Why?
|
| Labor, Obstetric | 1 | 2017 | 323 | 0.030 |
Why?
|
| Allied Health Personnel | 1 | 2015 | 155 | 0.030 |
Why?
|
| Rats, Wistar | 1 | 2017 | 1848 | 0.030 |
Why?
|
| Reverse Transcriptase Inhibitors | 1 | 1997 | 621 | 0.030 |
Why?
|
| Bone Marrow | 1 | 1984 | 2911 | 0.030 |
Why?
|
| Institutionalization | 1 | 1994 | 105 | 0.030 |
Why?
|
| NAD | 1 | 2017 | 614 | 0.030 |
Why?
|
| Attitude to Health | 1 | 1982 | 2025 | 0.030 |
Why?
|
| Fluid Therapy | 1 | 2017 | 579 | 0.030 |
Why?
|
| Infusion Pumps | 1 | 2014 | 163 | 0.030 |
Why?
|
| DNA, Mitochondrial | 1 | 2018 | 865 | 0.030 |
Why?
|
| Norepinephrine | 2 | 2010 | 897 | 0.030 |
Why?
|
| Factor Analysis, Statistical | 1 | 2016 | 999 | 0.030 |
Why?
|
| Infant, Newborn | 4 | 2019 | 26198 | 0.030 |
Why?
|
| Standard of Care | 1 | 2017 | 551 | 0.030 |
Why?
|
| Pregnancy Trimester, First | 1 | 2017 | 907 | 0.030 |
Why?
|
| Drug Administration Schedule | 2 | 2019 | 4853 | 0.030 |
Why?
|
| Anesthesia | 1 | 2004 | 1594 | 0.030 |
Why?
|
| Herpes Simplex | 1 | 1996 | 478 | 0.030 |
Why?
|
| Cyclooxygenase 2 | 2 | 2005 | 597 | 0.030 |
Why?
|
| Demyelinating Diseases | 1 | 2015 | 351 | 0.030 |
Why?
|
| Enalapril | 1 | 2014 | 312 | 0.030 |
Why?
|
| Cognition | 2 | 2013 | 6990 | 0.030 |
Why?
|
| Epinephrine | 2 | 2010 | 792 | 0.030 |
Why?
|
| Cytokines | 2 | 2017 | 7396 | 0.020 |
Why?
|
| Cross Reactions | 1 | 2014 | 817 | 0.020 |
Why?
|
| Professional Practice | 1 | 2014 | 313 | 0.020 |
Why?
|
| Cross-Sectional Studies | 3 | 2018 | 26125 | 0.020 |
Why?
|
| Cardiovascular Diseases | 1 | 2017 | 15500 | 0.020 |
Why?
|
| Neck | 1 | 2016 | 734 | 0.020 |
Why?
|
| Adiponectin | 1 | 2017 | 1113 | 0.020 |
Why?
|
| Homes for the Aged | 1 | 1994 | 272 | 0.020 |
Why?
|
| Tissue Adhesions | 1 | 2012 | 218 | 0.020 |
Why?
|
| Pandemics | 2 | 2022 | 8654 | 0.020 |
Why?
|
| Cytomegalovirus Infections | 1 | 1998 | 831 | 0.020 |
Why?
|
| Organ Size | 1 | 2016 | 2254 | 0.020 |
Why?
|
| Postmenopause | 4 | 2003 | 2513 | 0.020 |
Why?
|
| Hyperemia | 1 | 2012 | 221 | 0.020 |
Why?
|
| Thalamus | 1 | 2017 | 1045 | 0.020 |
Why?
|
| Recovery of Function | 3 | 2008 | 2979 | 0.020 |
Why?
|
| Behavior | 1 | 1994 | 541 | 0.020 |
Why?
|
| Myoglobin | 1 | 2011 | 159 | 0.020 |
Why?
|
| Breast Feeding | 1 | 2019 | 1359 | 0.020 |
Why?
|
| Child, Preschool | 4 | 2016 | 42230 | 0.020 |
Why?
|
| Pruritus | 1 | 2014 | 380 | 0.020 |
Why?
|
| Education, Medical, Continuing | 1 | 2016 | 823 | 0.020 |
Why?
|
| Patient Education as Topic | 1 | 2021 | 2319 | 0.020 |
Why?
|
| Thyroid Diseases | 1 | 2014 | 386 | 0.020 |
Why?
|
| Communication Aids for Disabled | 1 | 2010 | 56 | 0.020 |
Why?
|
| Glucose Transport Proteins, Facilitative | 1 | 2010 | 57 | 0.020 |
Why?
|
| Progesterone Congeners | 1 | 2010 | 44 | 0.020 |
Why?
|
| Biopsy | 3 | 2012 | 6766 | 0.020 |
Why?
|
| Apnea | 1 | 2012 | 195 | 0.020 |
Why?
|
| Salvage Therapy | 1 | 1997 | 1264 | 0.020 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2014 | 12148 | 0.020 |
Why?
|
| Stress, Psychological | 1 | 1986 | 4481 | 0.020 |
Why?
|
| Back Pain | 1 | 2014 | 545 | 0.020 |
Why?
|
| Interleukin-6 | 1 | 2000 | 3208 | 0.020 |
Why?
|
| Bradycardia | 1 | 2012 | 299 | 0.020 |
Why?
|
| Corneal Diseases | 1 | 2016 | 542 | 0.020 |
Why?
|
| Stimulation, Chemical | 1 | 2010 | 306 | 0.020 |
Why?
|
| Hexokinase | 1 | 2010 | 124 | 0.020 |
Why?
|
| Ureter | 1 | 2012 | 367 | 0.020 |
Why?
|
| Video Recording | 1 | 2015 | 966 | 0.020 |
Why?
|
| Manometry | 1 | 2012 | 454 | 0.020 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2004 | 3205 | 0.020 |
Why?
|
| Foreign Medical Graduates | 1 | 2010 | 77 | 0.020 |
Why?
|
| Veins | 2 | 2004 | 768 | 0.020 |
Why?
|
| Antineoplastic Agents | 3 | 2011 | 13639 | 0.020 |
Why?
|
| Deoxyglucose | 1 | 2010 | 333 | 0.020 |
Why?
|
| Administration, Oral | 2 | 2013 | 4021 | 0.020 |
Why?
|
| Infant | 3 | 2016 | 36192 | 0.020 |
Why?
|
| Hematocrit | 1 | 2011 | 623 | 0.020 |
Why?
|
| Blood Flow Velocity | 1 | 2013 | 1371 | 0.020 |
Why?
|
| Survival Rate | 2 | 2016 | 12725 | 0.020 |
Why?
|
| Membrane Proteins | 2 | 2004 | 7856 | 0.020 |
Why?
|
| Liver Function Tests | 1 | 2011 | 523 | 0.020 |
Why?
|
| Aorta | 1 | 2017 | 2042 | 0.020 |
Why?
|
| Aspartate Aminotransferases | 1 | 2011 | 416 | 0.020 |
Why?
|
| Resuscitation | 1 | 2014 | 673 | 0.020 |
Why?
|
| Kidney Neoplasms | 1 | 2006 | 4249 | 0.020 |
Why?
|
| Telemetry | 1 | 2010 | 199 | 0.020 |
Why?
|
| Fluorouracil | 2 | 2011 | 1641 | 0.020 |
Why?
|
| Nutritional Status | 1 | 2017 | 1615 | 0.020 |
Why?
|
| Patient Preference | 1 | 2016 | 924 | 0.020 |
Why?
|
| United States | 4 | 2019 | 72334 | 0.020 |
Why?
|
| Mass Screening | 2 | 2021 | 5428 | 0.020 |
Why?
|
| Social Environment | 1 | 1994 | 1020 | 0.020 |
Why?
|
| Heart Failure | 2 | 2003 | 11669 | 0.020 |
Why?
|
| Acute Disease | 5 | 1986 | 7237 | 0.020 |
Why?
|
| Electromyography | 1 | 2014 | 1394 | 0.020 |
Why?
|
| Child | 5 | 2016 | 80153 | 0.020 |
Why?
|
| Propensity Score | 1 | 2016 | 1913 | 0.020 |
Why?
|
| Pulmonary Artery | 1 | 2017 | 1927 | 0.020 |
Why?
|
| Hemorrhage | 1 | 2020 | 3424 | 0.020 |
Why?
|
| Platelet Count | 1 | 2011 | 781 | 0.020 |
Why?
|
| Alanine Transaminase | 1 | 2011 | 603 | 0.020 |
Why?
|
| Linear Models | 1 | 2018 | 5871 | 0.020 |
Why?
|
| Longitudinal Studies | 3 | 2019 | 14605 | 0.020 |
Why?
|
| Obesity | 1 | 2010 | 12947 | 0.020 |
Why?
|
| Mother-Child Relations | 1 | 2012 | 495 | 0.020 |
Why?
|
| Alkaline Phosphatase | 1 | 2011 | 864 | 0.020 |
Why?
|
| Food Deprivation | 1 | 1988 | 114 | 0.020 |
Why?
|
| Outpatient Clinics, Hospital | 1 | 2010 | 395 | 0.020 |
Why?
|
| Probability | 2 | 2003 | 2477 | 0.020 |
Why?
|
| Disease Management | 1 | 2018 | 2508 | 0.020 |
Why?
|
| Methotrexate | 2 | 2011 | 1719 | 0.020 |
Why?
|
| Plasmapheresis | 1 | 1987 | 206 | 0.020 |
Why?
|
| Candidiasis | 1 | 1989 | 365 | 0.020 |
Why?
|
| Leukocyte Count | 1 | 2011 | 1596 | 0.020 |
Why?
|
| Tamoxifen | 1 | 2011 | 965 | 0.020 |
Why?
|
| Premature Birth | 1 | 2019 | 1782 | 0.020 |
Why?
|
| Regression Analysis | 3 | 2010 | 6343 | 0.020 |
Why?
|
| Quality Assurance, Health Care | 2 | 2010 | 2169 | 0.020 |
Why?
|
| Fruit | 1 | 2012 | 1160 | 0.020 |
Why?
|
| Vegetables | 1 | 2012 | 1195 | 0.020 |
Why?
|
| Decision Support Techniques | 1 | 2017 | 1998 | 0.020 |
Why?
|
| Software | 2 | 2012 | 4434 | 0.020 |
Why?
|
| Deltaretrovirus | 1 | 1986 | 162 | 0.020 |
Why?
|
| Body Water | 1 | 1988 | 340 | 0.020 |
Why?
|
| Drug Therapy, Combination | 2 | 2014 | 6310 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2017 | 6484 | 0.020 |
Why?
|
| Single-Blind Method | 1 | 2010 | 1572 | 0.020 |
Why?
|
| Delirium | 1 | 2018 | 1668 | 0.020 |
Why?
|
| Midodrine | 1 | 2006 | 24 | 0.020 |
Why?
|
| Urinary Bladder | 1 | 2012 | 1152 | 0.020 |
Why?
|
| Clinical Trials as Topic | 1 | 1982 | 8002 | 0.020 |
Why?
|
| Psychometrics | 1 | 2016 | 3065 | 0.020 |
Why?
|
| Nursing Homes | 1 | 1994 | 1082 | 0.020 |
Why?
|
| Pyrimidines | 1 | 2018 | 3028 | 0.020 |
Why?
|
| Models, Biological | 2 | 2017 | 9469 | 0.020 |
Why?
|
| Infant, Premature, Diseases | 1 | 2012 | 710 | 0.020 |
Why?
|
| Disease-Free Survival | 1 | 2016 | 6814 | 0.020 |
Why?
|
| Hemophilia B | 1 | 1986 | 84 | 0.020 |
Why?
|
| Pregnancy Complications | 1 | 2000 | 2947 | 0.020 |
Why?
|
| Comorbidity | 3 | 2012 | 10508 | 0.020 |
Why?
|
| Robotics | 1 | 2012 | 819 | 0.020 |
Why?
|
| Biological Transport | 1 | 2010 | 2091 | 0.020 |
Why?
|
| Survival Analysis | 3 | 2005 | 10090 | 0.020 |
Why?
|
| Macaca fascicularis | 1 | 1988 | 903 | 0.020 |
Why?
|
| Sclerosis | 1 | 2006 | 210 | 0.020 |
Why?
|
| Tilt-Table Test | 1 | 2005 | 79 | 0.020 |
Why?
|
| Metoclopramide | 1 | 1985 | 51 | 0.020 |
Why?
|
| Leukopenia | 1 | 1986 | 213 | 0.020 |
Why?
|
| Respiration, Artificial | 1 | 2017 | 2628 | 0.020 |
Why?
|
| Nurses | 1 | 2015 | 2478 | 0.020 |
Why?
|
| Coronary Angiography | 1 | 2017 | 4471 | 0.020 |
Why?
|
| Embryo Implantation | 1 | 2007 | 270 | 0.020 |
Why?
|
| Histology | 1 | 2004 | 16 | 0.020 |
Why?
|
| Physician-Patient Relations | 2 | 2012 | 3249 | 0.020 |
Why?
|
| Psychomotor Performance | 1 | 2013 | 1881 | 0.020 |
Why?
|
| Hand Strength | 1 | 2008 | 456 | 0.020 |
Why?
|
| Neoplasms | 5 | 1986 | 22170 | 0.020 |
Why?
|
| Tumor Burden | 1 | 2011 | 1893 | 0.020 |
Why?
|
| Doxorubicin | 1 | 2011 | 2224 | 0.020 |
Why?
|
| Stromal Cells | 1 | 2010 | 1330 | 0.010 |
Why?
|
| Spatial Behavior | 1 | 1984 | 88 | 0.010 |
Why?
|
| Serum Albumin | 1 | 1988 | 672 | 0.010 |
Why?
|
| Family | 2 | 2005 | 3194 | 0.010 |
Why?
|
| Medical Records | 1 | 2010 | 1408 | 0.010 |
Why?
|
| Endocrine Glands | 1 | 2004 | 102 | 0.010 |
Why?
|
| Patient Discharge | 1 | 2017 | 3443 | 0.010 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2006 | 695 | 0.010 |
Why?
|
| Maternal Age | 1 | 2007 | 809 | 0.010 |
Why?
|
| Colorectal Neoplasms | 1 | 2004 | 6935 | 0.010 |
Why?
|
| Hospitals | 1 | 2017 | 3882 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2016 | 10766 | 0.010 |
Why?
|
| Kidney Function Tests | 1 | 2006 | 678 | 0.010 |
Why?
|
| Eicosapentaenoic Acid | 1 | 2008 | 561 | 0.010 |
Why?
|
| Prevalence | 3 | 2010 | 15732 | 0.010 |
Why?
|
| Nurse-Patient Relations | 1 | 2004 | 100 | 0.010 |
Why?
|
| Benzothiadiazines | 1 | 2003 | 31 | 0.010 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 1 | 2004 | 318 | 0.010 |
Why?
|
| Self Report | 1 | 2015 | 3724 | 0.010 |
Why?
|
| Radiography, Interventional | 1 | 2011 | 1121 | 0.010 |
Why?
|
| Ambulatory Care Facilities | 1 | 2010 | 935 | 0.010 |
Why?
|
| Body Weight | 2 | 2000 | 4618 | 0.010 |
Why?
|
| Vasomotor System | 1 | 2004 | 207 | 0.010 |
Why?
|
| Program Evaluation | 1 | 2012 | 2495 | 0.010 |
Why?
|
| Antibodies | 1 | 2011 | 2418 | 0.010 |
Why?
|
| Nitric Oxide | 1 | 2012 | 2135 | 0.010 |
Why?
|
| Databases, Factual | 1 | 2019 | 7967 | 0.010 |
Why?
|
| HIV Infections | 2 | 2000 | 17351 | 0.010 |
Why?
|
| Sodium Chloride Symporter Inhibitors | 1 | 2003 | 78 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 4575 | 0.010 |
Why?
|
| Hospitalization | 2 | 2019 | 10723 | 0.010 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2011 | 3514 | 0.010 |
Why?
|
| Ambulatory Care | 1 | 2014 | 2775 | 0.010 |
Why?
|
| Hemophilia A | 1 | 1986 | 360 | 0.010 |
Why?
|
| Space Flight | 1 | 2005 | 215 | 0.010 |
Why?
|
| Cluster Analysis | 1 | 2010 | 2707 | 0.010 |
Why?
|
| Acetylation | 1 | 2005 | 1055 | 0.010 |
Why?
|
| Health Personnel | 1 | 2016 | 3335 | 0.010 |
Why?
|
| Amlodipine | 1 | 2003 | 84 | 0.010 |
Why?
|
| Kidney Tubules | 1 | 2005 | 449 | 0.010 |
Why?
|
| Glucose Clamp Technique | 1 | 2003 | 263 | 0.010 |
Why?
|
| Kinetics | 1 | 2010 | 6374 | 0.010 |
Why?
|
| Laboratories, Hospital | 1 | 2004 | 192 | 0.010 |
Why?
|
| Vascular Resistance | 1 | 2005 | 930 | 0.010 |
Why?
|
| Educational Measurement | 1 | 2009 | 1254 | 0.010 |
Why?
|
| Control Groups | 1 | 1982 | 104 | 0.010 |
Why?
|
| Regional Blood Flow | 1 | 2005 | 1496 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2019 | 20570 | 0.010 |
Why?
|
| Digestive System | 1 | 2003 | 244 | 0.010 |
Why?
|
| Medicine | 1 | 2010 | 942 | 0.010 |
Why?
|
| Atrial Natriuretic Factor | 1 | 2003 | 350 | 0.010 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2006 | 2469 | 0.010 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2010 | 2010 | 0.010 |
Why?
|
| Administration, Intravaginal | 1 | 2001 | 150 | 0.010 |
Why?
|
| Monitoring, Physiologic | 1 | 2009 | 1779 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 1 | 2010 | 6216 | 0.010 |
Why?
|
| Potassium, Dietary | 1 | 2001 | 103 | 0.010 |
Why?
|
| Quality of Life | 2 | 2016 | 13367 | 0.010 |
Why?
|
| Placebos | 1 | 2005 | 1667 | 0.010 |
Why?
|
| Up-Regulation | 1 | 2010 | 4124 | 0.010 |
Why?
|
| Cerebral Cortex | 1 | 2017 | 5777 | 0.010 |
Why?
|
| Arteries | 1 | 2006 | 1123 | 0.010 |
Why?
|
| Laparoscopy | 1 | 2012 | 2035 | 0.010 |
Why?
|
| Sampling Studies | 1 | 2002 | 615 | 0.010 |
Why?
|
| Nephrectomy | 1 | 2006 | 937 | 0.010 |
Why?
|
| Odds Ratio | 2 | 2010 | 9646 | 0.010 |
Why?
|
| Quality Improvement | 1 | 2016 | 3801 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2010 | 9000 | 0.010 |
Why?
|
| Drug Evaluation | 3 | 1986 | 641 | 0.010 |
Why?
|
| Cross Infection | 1 | 1989 | 1422 | 0.010 |
Why?
|
| Autonomic Nervous System | 1 | 2005 | 703 | 0.010 |
Why?
|
| Hyperinsulinism | 1 | 2003 | 400 | 0.010 |
Why?
|
| Psychological Theory | 1 | 1981 | 175 | 0.010 |
Why?
|
| Equipment Design | 1 | 2008 | 3510 | 0.010 |
Why?
|
| Isoenzymes | 1 | 2004 | 1687 | 0.010 |
Why?
|
| Citric Acid | 1 | 2000 | 123 | 0.010 |
Why?
|
| Menstrual Cycle | 1 | 2003 | 539 | 0.010 |
Why?
|
| Ovulation Induction | 1 | 2001 | 277 | 0.010 |
Why?
|
| Logistic Models | 2 | 2005 | 13255 | 0.010 |
Why?
|
| Calcium Channel Blockers | 1 | 2003 | 694 | 0.010 |
Why?
|
| Homeostasis | 1 | 2010 | 3323 | 0.010 |
Why?
|
| Internal-External Control | 1 | 1981 | 358 | 0.010 |
Why?
|
| Phantoms, Imaging | 1 | 2008 | 2526 | 0.010 |
Why?
|
| Guideline Adherence | 1 | 2009 | 2220 | 0.010 |
Why?
|
| Recurrence | 1 | 2012 | 8465 | 0.010 |
Why?
|
| Iron | 1 | 1988 | 1793 | 0.010 |
Why?
|
| Lymph Node Excision | 1 | 1985 | 1271 | 0.010 |
Why?
|
| Diabetic Nephropathies | 1 | 2006 | 973 | 0.010 |
Why?
|
| Neurotransmitter Agents | 1 | 2003 | 665 | 0.010 |
Why?
|
| Methadone | 1 | 1981 | 321 | 0.010 |
Why?
|
| Environment | 1 | 1984 | 1123 | 0.010 |
Why?
|
| Blood Pressure Determination | 1 | 2002 | 633 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2016 | 11528 | 0.010 |
Why?
|
| Calcium | 2 | 2003 | 5722 | 0.010 |
Why?
|
| Dehydroepiandrosterone | 1 | 1999 | 258 | 0.010 |
Why?
|
| Melanoma | 2 | 1988 | 5709 | 0.010 |
Why?
|
| Diphosphonates | 1 | 2003 | 636 | 0.010 |
Why?
|
| Communication | 1 | 2012 | 3873 | 0.010 |
Why?
|
| Patient Selection | 1 | 2010 | 4244 | 0.010 |
Why?
|
| Biopsy, Needle | 1 | 2003 | 1626 | 0.010 |
Why?
|
| Coronary Artery Disease | 1 | 2017 | 6403 | 0.010 |
Why?
|
| Neoplasm Staging | 2 | 2010 | 11121 | 0.010 |
Why?
|
| Exercise Test | 1 | 2005 | 2127 | 0.010 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2003 | 1241 | 0.010 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2012 | 4016 | 0.010 |
Why?
|
| Adrenocorticotropic Hormone | 1 | 1999 | 618 | 0.010 |
Why?
|
| Vitamin D | 2 | 2003 | 3303 | 0.010 |
Why?
|
| Ethics, Medical | 1 | 1982 | 783 | 0.010 |
Why?
|
| Family Health | 1 | 2002 | 1257 | 0.010 |
Why?
|
| Prolactin | 1 | 1999 | 625 | 0.010 |
Why?
|
| Cardiovascular System | 1 | 2004 | 834 | 0.010 |
Why?
|
| Brain Injuries | 1 | 2008 | 2053 | 0.010 |
Why?
|
| Risk | 2 | 1986 | 9610 | 0.010 |
Why?
|
| Animals | 3 | 2017 | 168459 | 0.010 |
Why?
|
| Statistics, Nonparametric | 1 | 2001 | 2850 | 0.010 |
Why?
|
| Area Under Curve | 1 | 2000 | 1638 | 0.010 |
Why?
|
| Inflammation Mediators | 1 | 2004 | 1886 | 0.010 |
Why?
|
| Collagen Type I | 1 | 1999 | 616 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2010 | 12795 | 0.010 |
Why?
|
| Models, Theoretical | 1 | 1987 | 3575 | 0.010 |
Why?
|
| Data Collection | 1 | 2004 | 3322 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2010 | 18965 | 0.010 |
Why?
|
| Brain Mapping | 1 | 2010 | 6630 | 0.010 |
Why?
|
| Demography | 1 | 1999 | 1648 | 0.010 |
Why?
|
| Sex Distribution | 1 | 1999 | 2281 | 0.010 |
Why?
|
| Intermediate Care Facilities | 1 | 1994 | 12 | 0.010 |
Why?
|
| Heart Rate | 1 | 2006 | 4195 | 0.010 |
Why?
|
| Psychology, Social | 1 | 1994 | 52 | 0.010 |
Why?
|
| Natriuretic Peptide, Brain | 1 | 2003 | 1723 | 0.010 |
Why?
|
| Administration, Topical | 1 | 1996 | 704 | 0.010 |
Why?
|
| Receptors, Cell Surface | 1 | 2003 | 2822 | 0.010 |
Why?
|
| Philadelphia | 1 | 1994 | 266 | 0.010 |
Why?
|
| Drug Resistance, Microbial | 1 | 1996 | 825 | 0.010 |
Why?
|
| Motivation | 1 | 1982 | 2006 | 0.010 |
Why?
|
| Restraint, Physical | 1 | 1994 | 187 | 0.010 |
Why?
|
| Guidelines as Topic | 1 | 1999 | 1386 | 0.010 |
Why?
|
| Estrogen Replacement Therapy | 1 | 1999 | 1208 | 0.010 |
Why?
|
| Electrocardiography | 1 | 2005 | 6377 | 0.010 |
Why?
|
| Oxidative Stress | 1 | 2003 | 3113 | 0.010 |
Why?
|
| Psychological Tests | 1 | 1994 | 640 | 0.010 |
Why?
|
| CD4 Lymphocyte Count | 1 | 1998 | 2571 | 0.010 |
Why?
|
| Birth Weight | 1 | 2000 | 2103 | 0.010 |
Why?
|
| Polymorphism, Genetic | 1 | 2002 | 4243 | 0.010 |
Why?
|
| Safety | 1 | 1996 | 1150 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2000 | 6228 | 0.010 |
Why?
|
| Mental Health | 1 | 1986 | 3250 | 0.010 |
Why?
|
| Antihypertensive Agents | 1 | 2000 | 2024 | 0.010 |
Why?
|
| Skilled Nursing Facilities | 1 | 1994 | 398 | 0.010 |
Why?
|
| Thyroid Neoplasms | 1 | 2003 | 2332 | 0.010 |
Why?
|
| Heart Diseases | 1 | 1982 | 2781 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2003 | 12059 | 0.010 |
Why?
|
| Stroke Volume | 1 | 2003 | 5496 | 0.010 |
Why?
|
| Pregnancy Outcome | 1 | 2000 | 2921 | 0.010 |
Why?
|
| T-Lymphocytes | 1 | 1986 | 10194 | 0.000 |
Why?
|
| Pennsylvania | 1 | 1989 | 613 | 0.000 |
Why?
|
| Models, Statistical | 1 | 2003 | 5079 | 0.000 |
Why?
|
| Hospitals, University | 1 | 1989 | 563 | 0.000 |
Why?
|
| Algorithms | 1 | 2008 | 14031 | 0.000 |
Why?
|
| Genotype | 1 | 2002 | 12990 | 0.000 |
Why?
|
| Catheters, Indwelling | 1 | 1989 | 426 | 0.000 |
Why?
|
| Peptides | 1 | 1999 | 4358 | 0.000 |
Why?
|
| False Negative Reactions | 1 | 1988 | 573 | 0.000 |
Why?
|
| Factor IX | 1 | 1986 | 77 | 0.000 |
Why?
|
| Actuarial Analysis | 1 | 1985 | 372 | 0.000 |
Why?
|
| Evaluation Studies as Topic | 1 | 1987 | 1624 | 0.000 |
Why?
|
| Pleurisy | 1 | 1985 | 54 | 0.000 |
Why?
|
| Akathisia, Drug-Induced | 1 | 1985 | 67 | 0.000 |
Why?
|
| Leukemia, Lymphoid | 1 | 1985 | 310 | 0.000 |
Why?
|
| Amphotericin B | 1 | 1985 | 142 | 0.000 |
Why?
|
| Inflammation | 1 | 2005 | 10773 | 0.000 |
Why?
|
| Paranasal Sinus Diseases | 1 | 1985 | 121 | 0.000 |
Why?
|
| Factor VIII | 1 | 1986 | 348 | 0.000 |
Why?
|
| Vomiting | 1 | 1986 | 651 | 0.000 |
Why?
|
| Mice | 1 | 2010 | 81525 | 0.000 |
Why?
|
| Communicable Disease Control | 1 | 1989 | 846 | 0.000 |
Why?
|
| Prednisone | 1 | 1988 | 1563 | 0.000 |
Why?
|
| Computers | 1 | 1985 | 593 | 0.000 |
Why?
|
| Patient Transfer | 1 | 1989 | 794 | 0.000 |
Why?
|
| Cough | 1 | 1985 | 594 | 0.000 |
Why?
|
| Chronic Disease | 1 | 1996 | 9318 | 0.000 |
Why?
|
| Respiratory Sounds | 1 | 1985 | 702 | 0.000 |
Why?
|
| Hypotension | 1 | 1986 | 879 | 0.000 |
Why?
|
| Cause of Death | 1 | 1991 | 3683 | 0.000 |
Why?
|
| Disease Progression | 1 | 1997 | 13506 | 0.000 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 1986 | 3810 | 0.000 |
Why?
|
| Epidemiologic Methods | 1 | 1984 | 1336 | 0.000 |
Why?
|
| Cisplatin | 1 | 1985 | 1651 | 0.000 |
Why?
|
| Adrenal Cortex Hormones | 1 | 1987 | 1880 | 0.000 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 1988 | 9280 | 0.000 |
Why?
|
| Diagnostic Errors | 1 | 1985 | 1265 | 0.000 |
Why?
|
| Fever | 1 | 1985 | 1618 | 0.000 |
Why?
|
| Combined Modality Therapy | 1 | 1988 | 8529 | 0.000 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 1987 | 2751 | 0.000 |
Why?
|
| Radiography | 1 | 1985 | 6965 | 0.000 |
Why?
|
| Palliative Care | 1 | 1986 | 3598 | 0.000 |
Why?
|
| Pain | 1 | 1985 | 5073 | 0.000 |
Why?
|
| Diagnosis, Differential | 1 | 1985 | 12974 | 0.000 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 1985 | 3613 | 0.000 |
Why?
|